期刊文献+

Bcl-2基因多态性与乳腺癌临床生物学指标的关系 被引量:10

Correlation of Bcl-2 polymorphism with clinical biological behaviors of breast cancer
下载PDF
导出
摘要 目的:探讨凋亡基因Bcl-2启动子区C(-938)A单核苷酸多态性(snigle nucleotide polymorphism,SNP)与河北省乳腺癌患者临床生物学指标的关系。方法:采用聚合酶链反应-限制性酶切片段长度多态性分析(polymerase chain reaction-restriction fragment length polymorphism,PCR-RFLP)方法检测113例乳腺癌患者Bcl-2基因C(-938)A SNP的3个基因型(即AA、AC和CC),并与临床生物学指标相关联,比较各组间基因型频率的分布情况。结果:按腋淋巴结转移个数进行分层分析,AA型和AC+CC型在无转移、1~3个转移、≥4个转移组中分别占26.8%、47.8%、52.6%和73.2%、52.2%、47.4%,两组比较差异有统计学意义(χ2=6.337,P=0.042);与AC+CC型相比,AA型在≥4个转移组OR值为3.041(95%CI:1.072~8.626)。在组织学分级中,AA型和AC+CC型在Ⅰ~Ⅱ级、Ⅲ级中分别占30.9%、57.9%和69.1%、42.1%,两组基因型分布差异有统计学意义(χ2=5.055,P=0.025);与AC+CC型相比,AA型在肿瘤分化Ⅲ级组中OR值为3.082(95%CI:1.122~8.465)。按雌激素受体(estrogen receptor,ER)、孕激素受体(progesterone receptor,PR)和C-erbB2蛋白表达水平进行分层分析,发现AA型和AC+CC型的上述指标分布差异无统计学意义(χ2=3.005,χ2=1.504,χ2=1.163;P〉0.05)。结论:乳腺癌患者Bcl-2基因C(-938)A SNP的AA基因型与其腋淋巴结转移率较高和肿瘤组织分化较差相关。 Objective:To study the correlation of C(-938)A single nucleotide polymorphism(SNP) in the promoter of anti-apoptosis gene Bcl-2 with the clinical biological parameters of breast cancer patients in Hebei Province.Methods:Three genotypes(AA,AC,CC) of Bcl-2 C(-938)A from 113 samples of breast cancer patients were analyzed by using polymerase chain reaction-restriction fragment length polymorphism(PCR-RFLP) method,and the results were associated with clinical biological parameters.The distribution of genotype frequency was compared between different groups.Results:When stratified for axillary lymph node metastases,the frequency of AA genotype were 26.8%,47.8% and 52.6% and the distribution of AC+CC genotypes were 73.2%,52.2% and 47.4% in negative group,1-3 metastasis group,and ≥4 metastasis group.The difference between the two groups was significant(χ2=6.337,P=0.042).Compared with the AC+CC genotypes,the OR value of AA genotype in ≥4 metastasis group was 3.041(95%CI=1.072-8.626).The frequency of AA genotype were 30.9% and 69.1% in gradeⅠ-Ⅱ group and grade Ⅲ group,and the frequency of AC+CC genotypes were 57.9% and 42.1%.The difference between the two groups was significant(χ2=5.055;P=0.025).Compared with the AC+CC genotypes,the OR value of AA genotype in differentiated tumors(grade Ⅲ)was 3.082(95%CI=1.122-8.465).Stratified for estrogen receptor(ER),progesterone receptor(PR) and C-erbB2,there was no difference between the distribution of AA genotype and AC+CC genotypes(χ2=3.005,χ2=1.504,χ2=1.163,P0.05).Conclusion:The AA genotype of Bcl-2 gene C(-938)A maybe correlated with high lymph node metastasis rate and poor differentiation.
出处 《肿瘤》 CAS CSCD 北大核心 2010年第1期48-52,共5页 Tumor
基金 河北省高等院校强势特色学科资金资助项目(编号:冀教高[2005]52号) 河北省医学适用技术跟踪项目(编号:GL200520)
关键词 乳腺肿瘤 基因 BCL-2 多态性 单核苷酸 聚合酶链反应-限制性酶切片段长度多态性分析 Breast neoplasms Genes bcl-2 Polymorphism single nucleotide Polymerase chain reaction-restriction fragment length polymorphism
  • 相关文献

参考文献9

  • 1LEHNERDT G F, FRANZ P, BANKFALVI A, et al. The regulatory BCL2 promoter polymorphism ( -938C > A) is associated with relapse and survival of patients with oropharyngeal squamous cell carcinoma[ J]. Ann Oncol,2009,20 (6) : 1094-1099.
  • 2KIDD L R, COULIBALY A,TEMPLTON T M, et al. Germline BCL-2 sequence variants and inherited predisposition to prostate cancer [ J ]. Prostate Cancer Prostatic Dis,2006, 9 ( 3 ) :284-292.
  • 3HIRATA H, HINODA Y, NAKAJIMA K,et al. The Bc12-938CC genotype has poor prognosis and lower survival in renal cancer [ J ]. J Urol,2009,182(2) :721-727.
  • 4CALLAGY G M, WEBBER M J, PHAROAH P D, et al. Meta- analysis confirms BCL2 is an independent prognostic marker in breast cancer [ J ]. BMC Cancer,2008,29 ( 8 ) : 153.
  • 5BACHMANN H S, OTTERBACH F, CALTIES R,et al. The AA genotype of the regulatory Bcl-2 promoter polymorphism( -938C > A) is associated with a favorable outcome in lymph node-negative invasive breast cancer patients [ J ]. Clin Cancer Res, 2007, 13 ( 19 ) :5790-5797.
  • 6MILLER S A, DYBES D D, POLESKY H F. A simple salting out procedure for extracting DNA from human nucleated cells[ J]. Nucleic Acid Res, 1988,16 (3) :1215.
  • 7YOUNG R L, KORSMEYER S J. A negative regulatory element in the Bcl-2 5 '-untranslated region inhibits expression from an up- stream promoter [ J]. Mol Cell Biol, 1993,13 (6) : 3686-3697.
  • 8NUCKEL H,FREY U H,BAU M,et al. Association of a novel regulatory polymorphism ( - 938C > A) in the Bcl-2 gene promoter with disease progression and survival in chronic lymphocytic leukemia [J]. Blood,2007,109( 1 ) :290-297.
  • 9OLTVAI Z N, MILLIMAN C L, KORSMEYER S J. Bcl-2 hetero-dimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death[ J]. Cell,1993,74(4) : 609-619.

同被引文献83

引证文献10

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部